{"name":"Biosolution Co., Ltd.","slug":"biosolution-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous cultured keratinocyte cell","genericName":"Autologous cultured keratinocyte cell","slug":"autologous-cultured-keratinocyte-cell","indication":"Severe burns","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CartiLife","genericName":"CartiLife","slug":"cartilife","indication":"Cartilage defects or osteoarthritis (presumed, based on product name)","status":"phase_2"}]}],"pipeline":[{"name":"Autologous cultured keratinocyte cell","genericName":"Autologous cultured keratinocyte cell","slug":"autologous-cultured-keratinocyte-cell","phase":"phase_3","mechanism":"Autologous cultured keratinocytes are patient-derived skin cells grown in vitro and applied topically or as a graft to promote wound healing and tissue regeneration.","indications":["Severe burns","Chronic wounds","Diabetic ulcers"],"catalyst":""},{"name":"CartiLife","genericName":"CartiLife","slug":"cartilife","phase":"phase_2","mechanism":"CartiLife is a regenerative medicine therapy designed to repair or regenerate cartilage tissue, likely through cell-based or tissue engineering approaches.","indications":["Cartilage defects or osteoarthritis (presumed, based on product name)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBLQXlIRE16OHpNcnNHTFVrUHp5Y0VsRnQ5UXNBb1Q4d25FR3c4ekpVWk80b3pDQ0dnZXBOMEMzc0U4amFMZmFOc0dyRk1pWlE0?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-20","type":"pipeline","source":"simplywall.st","summary":"Institutional investors have a lot riding on Emergent BioSolutions Inc. (NYSE:EBS) with 73% ownership - simplywall.st","headline":"Institutional investors have a lot riding on Emergent BioSolutions Inc. (NYSE:EBS) with 73% ownership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNbFdFM3pRZDg5QmhuTU9tVDdGUjBaS0pSNVhFQTJ1NVhITWhlUVBJRUxDMTZiaHdVZk5NR3FGSWxTVkZMdHZtVU9HdUg4a2liSC1CRVVGODNYMmZsZDNfdVpkeDJ4aEdjN2ZNRFhoWVJuQm9UMXRyRzVPUUNkT0Y3N0w3elIxWjRHbUhsRnBPSTV0SDVyR1pMejZ1aVZ1UXg2dXZZMl9iV2dYOG9qektuQXEyN0o0OUIw?oc=5","date":"2025-08-11","type":"deal","source":"PR Newswire","summary":"Intas & Accord signs Agreement to acquire Prothya Biosolutions - PR Newswire","headline":"Intas & Accord signs Agreement to acquire Prothya Biosolutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUUxNMzdmY0xSSG8teHFGWlNfVmMyY1NLc0g5eEhNTVgyaVlHODZ0dlhaR2t3ZmpFZF9zR0luSUk0Wm9pbkdRUGFEbHFjVk43emRvU1BsVGVSVTJkTWVlSEhvaUI2R3dXSkszRng2M1pwR0x1R3hwS3VRbmFiSGQ2NWRHLWVMTTlwT0FBZGVBMng5RU9HcHJnTk9BYXFfd0ZYYlp1YXNOdmJyYkk?oc=5","date":"2025-04-03","type":"deal","source":"Contract Pharma","summary":"Artis BioSolutions Emerges from Stealth, Acquires Landmark Bio - Contract Pharma","headline":"Artis BioSolutions Emerges from Stealth, Acquires Landmark Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQUUJKRE5PelJubWtaR0tJUFlLdlpkNU1FLUJUWFFWLWVWVE84TGU4WnRwRVZGV0R0ZkhtQUM3YWw4c1h2Sk5zTEVfZ3V6ODgyU2xDRWw0cTZoUWpQZUlyWTRaN2dfdzdxUXNlOUVxQnI4U19DRllzQVNOYjhGS2htNXdHTEtTRHdORThBeC1kbThHa0JBNHJ6RDV3?oc=5","date":"2025-03-10","type":"pipeline","source":"The Business Journals","summary":"Drug manufacturer to sell Baltimore plant for $36.5M - The Business Journals","headline":"Drug manufacturer to sell Baltimore plant for $36.5M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPUWwtQWlFbmZHUFk1YXJTNmpuUGRYdkJjSUNMM1NhV1JPVWwwQ3dhYlp5NVY2QWZDbFdHVHFPcFl2QVdDaXB2M0xQeXhHSGRvN1ZISHVzYUFLT0IzWkVJTFNYUXc3azZYNkpfSGVocUpHM1pPOW5BQkItSkVKNU9iZ0RmYzF1aUpZbVBRZ2twUU1maDhLVUxuVmcyMHFOemx6UUJZN3RNU01Hc1dNOEtQdFpmeTU?oc=5","date":"2025-03-10","type":"pipeline","source":"Fierce Pharma","summary":"Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant - Fierce Pharma","headline":"Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1nXzhUSjhVU0t2aGZUMzhuU2ZVNkdsOGM4RUZpY1VabHU1RGFNcVNWZUhJaUxDa0YyeG1NU01ROFpZZ0FBaTM5TmsxVHBfbDM0ak1kY1luYkZoekJfMy13VmxlTUZTYndUN3Y1OWlR0gFyQVVfeXFMT2VGbU1KX3ZrdkRVTDFFNVE3b2tkcFdpUzBhSnNtZmlIZDYyX3hDd2IxamZFQ2E3RlBfUXdvRE1ockl3dWZJbU5URHdDLXRUNG1TNk1Cc1Z2UzliX3YxZzF4QjF1d0ZXX2lFc1ZZNlJPUWFn?oc=5","date":"2025-03-06","type":"trial","source":"koreabiomed.com","summary":"Bio Solution unveils positive phase 3 study results for autologous chondrocyte therapy CartiLife - koreabiomed.com","headline":"Bio Solution unveils positive phase 3 study results for autologous chondrocyte therapy CartiLife","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQX3FwcFhwT1lkVjNiV2VIX1lUM1hTcU5sWGdDS2hsQVhUcXc0QTU2V2YzeG5xTGZkN01QdmF1UHE2d1JMWUdjSGY5Z2Z6RHRfTy1uOVJkVmdKdU1CeXZQUmhtOEVHbjdvUkZoeXE4azh2UGY5Sm1oRi1nSWNwWHoyNGJ4UXdvQk1PNF9sX0lLaGNJOGZHTTZjVVJibFhtTlZxVk1YLXFEZ0VhSHBuLUww?oc=5","date":"2025-02-26","type":"pipeline","source":"BioSpace","summary":"Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace","headline":"Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPd244aGU2OERReVJxUlBpWVJhSGdvaXRpVlhHZzhuNDloSXcwUGpUWS01WjlRVUYyX1lYSXJhcmV1VTlJWGJTN0VybEF6elF0SlNaR3RDRUlPTnNGWE9iUFY1ZVExTTBneDlydWxMRGRCN0lXWWNHOEVvbnRVVUVJQzBUcVJqWWNibXhUUlc2VzhuZzdVVUUyenNKZThLVjBybE0wY0taWnV6UzVQSWttQlp4LTF3bUVMZTJxa29Ma0d1THRYU2c?oc=5","date":"2024-08-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals - Pharmaceutical Technology","headline":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQVmtDVUFNOF9RcGZQUUpBQnhVWldwY2wxUHdfdmtOYnI1RkJBUVJqVHpJVUpDWTBjVTNvX19WaHozV3hJRWNsUXV0eE1LNnM3SkNYdGlvTHlBb0lNRHRvRUlIelhNMGc4M1YzZ1VSckRWcll3Y1hWMjdSVHV0N0RTTjJxS2lENm16TTdIcm83emhWY1N1aldZRmczTkJRaHE3YjRZRTZCc1QwMkJZbHBjSEp5RXVSNWJwLU82Zk1aMGpZVV9UdV94UlhPNkRHU2ZJbFlYcDM5Wk13MHRkYm9nb0RqWkVkZDJVeENIRzloMHNCcDd4N1g1cw?oc=5","date":"2023-10-16","type":"pipeline","source":"Business Wire","summary":"KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma - Business Wire","headline":"KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPeVd5S0JqWFNyZFZMOHQyVVBSYkdpZ2JFNU9DaHRyazl3ZWE3cl9rUUcxdnJCRkdlVThjUE5FNnVLSU91WTFRd2pMbldWRS0tMXdkWk5jUTliX3RhRkZUOERpOXFSS3drSWtjMU9XZEl2VV90UnMxUkRRZzQxSlp3LUZOa1JIS1Y1V21OcW5UT2N2WWd0RG54Znhud0Fxb0swUTV3TzlHMDdZX2ZmdHc?oc=5","date":"2020-01-07","type":"pipeline","source":"BioSpectrum Asia","summary":"Mundipharma, Biosolution to market CartiLife in South Korea - BioSpectrum Asia","headline":"Mundipharma, Biosolution to market CartiLife in South Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNZjRLVGY3cVUxUEtITkExSFU4STlqYm9pU25wMk5FSkhEZ0FFMEFSekRmSDc4bnRMUzFLZHM4V3lJaW4xUkhwS21CdTljTDFxcnB6Q0RNQ2FoaVZHT0RaZGV0TzN4M1pZOExJUmRMZVFPaXFKRnp4a1dRZFRqYU56VW1OaHlLd3RlRjJ4VHNaLVQyRVEtcFNVNC1PUlp6c09GSXN5YkRDMVlxY1lTZ2lLSWNOUUUycFVJdnhhY1EzR05jWUVxeS1IUmxmS1VhV0RH?oc=5","date":"2020-01-06","type":"deal","source":"PR Newswire","summary":"Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea - PR Newswire","headline":"Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}